Cyclosporine‐induced gingival overgrowth—Review. Issue 12 (17th October 2022)

• Record Type: Journal Article
• Authors: Chojnacka‐Purpurowicz, Joanna; Wygonowska, Ewa; Placek, Waldemar; Owczarczyk‐Saczonek, Agnieszka
• Is Part Of: Dermatologic therapy. Volume 35:Issue 12(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-10-17
• Subjects: calcineurin inhibitor -- cyclosporine -- DIGO -- gingival overgrowth -- gingivectomy; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/dth.15912
• Languages: English
• ISSNs: 1396-0296

Abstract

Abstract: Drug‐induced gingival overgrowth (DIGO) is an undesirable effect resulting from the therapy of one of the three groups of drugs: phenytoin, calcium channel blockers, and cyclosporine A (CsA). It is caused by a fibrous overgrowth leading to gingivitis, periodontitis, and even tooth loss. Possible consequences include tooth decay worsening, pain and difficulty in eating, bleeding gums, and bad breath. The pathomechanism of the hypertrophy is unknown, but there is a correlation between insufficient oral hygiene and the severity of this phenomenon. The gender and age predilection of gingival hyperplasia as a result of CsA therapy is also noticeable. It is most common in children and adolescents of the male sex. The beneficial effect of the removal of tartar and local irritants in reducing the above symptoms has been demonstrated. One of the treatments for DIGO is conventional gingivectomy. The paper is a review article about cyclosporine‐induced gingival hyperplasia.